Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

James Healy

Affiliations

  • Director at Coherus Biosciences Inc. (CHRS), 2019-06-24
  • Large Shareholder, Director at Iterum Therapeutics Plc (ITRM), 2019-06-17
  • Director at Y-Mabs Therapeutics Inc. (YMAB), 2019-06-14
  • Director at Natera Inc. (NTRA), 2019-05-29
  • Large Shareholder at Nextcure Inc. (NXTC), 2019-05-15
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-20
  • Director at Edge Therapeutics Inc. (EDGE), 2017-06-21
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2016-10-24
  • Director at Amarin Corp Plc (AMRN), 2016-07-13
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2015-10-13
  • Large Shareholder at Mirna Therapeutics Inc. (MIRN), 2015-10-06
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder, Director at Hyperion Therapeutics Inc (HPTX), 2015-05-09
  • Large Shareholder at Spark Therapeutics Inc. (ONCE), 2015-01-30
  • Large Shareholder at Histogenics Corp (HSGX), 2014-12-10
  • Director at Intermune Inc (ITMN), 2014-10-02
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2014-09-15
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-12
  • Large Shareholder at Versartis Inc. (VSAR), 2014-03-28
  • Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2014-03-20
  • at Anthera Pharmaceuticals Inc (ANTH), 2013-05-20
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2013-05-03
  • Large Shareholder, Director at Durata Therapeutics Inc. (DRTX), 2012-07-25
  • Large Shareholder at Trius Therapeutics Inc (TSRX), 2012-01-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
YMAB $16.00 500,000 Director 2,104,278 2018-09-21 Filing
ITRM $13.00 500,000 Large Shareholder, Director 1,726,514 2018-05-30 Filing
EDGE $7.30 541,343 Director 2,852,711 2016-03-11 Filing
EDGE $11.00 450,000 Director 2,257,703 2015-10-06 Filing
NTRA $18.00 175,000 Director 375,000 2015-07-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CHRS $21.37 317,130 Director 2,293,221 2019-06-20 Filing
CHRS $20.69 257,870 Director 2,610,351 2019-05-22 Filing
CHRS $20.50 25,000 Director 2,868,221 2018-08-29 Filing
HPTX $27.70 417,747 Director 1,939,474 2014-06-04 Filing
HPTX $30.02 23,625 Large Shareholder, Director 0 2014-03-04 Filing